COMPLEGENT

Serial Number 77179157
Registration 3668133
710

Registration Progress

Application Filed
May 11, 2007
Under Examination
Approved for Publication
May 13, 2009
Published for Opposition
Jun 2, 2009
Registered
Aug 18, 2009

Trademark Image

COMPLEGENT

Basic Information

Serial Number
77179157
Registration Number
3668133
Filing Date
May 11, 2007
Registration Date
August 18, 2009
Published for Opposition
June 2, 2009
Cancellation Date
May 25, 2021
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
710
Status Date
May 25, 2021
Classes
005

Rights Holder

KYOWA KIRIN CO., LTD.

03
Address
1-9-2, OTEMACHI, CHIYODA-KU
TOKYO 100-0004
JP

Ownership History

KYOWA HAKKO KOGYO CO., LTD.

Original Applicant
03
Tokyo JP

KYOWA HAKKO KIRIN CO., LTD.

New Owner Before Publication #1
03
CHIYODA-KU, TOKYO JP

KYOWA HAKKO KIRIN CO., LTD.

Owner at Publication
03
CHIYODA-KU, TOKYO JP

KYOWA HAKKO KIRIN CO., LTD.

Original Registrant
03
CHIYODA-KU, TOKYO JP

KYOWA KIRIN CO., LTD.

New Owner After Registration #1
03
TOKYO JP

Legal Representation

Attorney
Kaushal Odedra

USPTO Deadlines

Next Deadline
1380 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2009-08-18)
Due Date
August 18, 2029
Grace Period Ends
February 18, 2030

Application History

50 events
Date Code Type Description Documents
May 26, 2021 NCS8 E NOTICE OF CANCELLATION SEC. 8 EMAILED Loading...
May 25, 2021 C8.T O CANCELLED SEC. 8 (10-YR) Loading...
May 25, 2021 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Apr 30, 2021 PCDE O PETITION TO DIRECTOR DENIED Loading...
Nov 2, 2020 APET A ASSIGNED TO PETITION STAFF Loading...
Jun 25, 2020 TPDR I TEAS PETITION TO DIRECTOR RECEIVED Loading...
Apr 1, 2020 PR89 O POST REGISTRATION ACTION MAILED - SEC. 8 & 9 Loading...
Mar 12, 2020 EROP I TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED Loading...
Nov 4, 2019 PR89 O POST REGISTRATION ACTION MAILED - SEC. 8 & 9 Loading...
Sep 11, 2019 EROP I TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED Loading...
Sep 11, 2019 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Sep 11, 2019 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Sep 4, 2019 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
May 30, 2019 PR89 O POST REGISTRATION ACTION MAILED - SEC. 8 & 9 Loading...
May 30, 2019 PR89 O POST REGISTRATION ACTION MAILED - SEC. 8 & 9 Loading...
May 16, 2019 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Apr 8, 2019 E89R I TEAS SECTION 8 & 9 RECEIVED Loading...
Aug 18, 2018 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Loading...
Sep 22, 2015 8.OK O REGISTERED - SEC. 8 (6-YR) ACCEPTED Loading...
Sep 22, 2015 8.PR O REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED Loading...
Sep 22, 2015 NAS8 E NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED Loading...
Sep 22, 2015 NAS8 E NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED Loading...
Sep 4, 2015 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Aug 17, 2015 ES8R I TEAS SECTION 8 RECEIVED Loading...
Aug 17, 2015 8.AF I REGISTERED - SEC. 8 (6-YR) FILED Loading...
Aug 18, 2009 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jun 2, 2009 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 13, 2009 NPUB O NOTICE OF PUBLICATION Loading...
Apr 29, 2009 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Apr 27, 2009 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 25, 2009 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Mar 25, 2009 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 25, 2009 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 2, 2009 CNSL S LETTER OF SUSPENSION MAILED Loading...
Mar 1, 2009 CNSL R SUSPENSION LETTER WRITTEN Loading...
Feb 9, 2009 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 9, 2009 ACEC I AMENDMENT FROM APPLICANT ENTERED Loading...
Feb 6, 2009 MAIL I PAPER RECEIVED Loading...
Jan 12, 2009 CNSI S INQUIRY AS TO SUSPENSION MAILED Loading...
Jan 11, 2009 CNSI R SUSPENSION INQUIRY WRITTEN Loading...
Jan 9, 2009 RCCK S SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Loading...
Nov 19, 2008 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Jul 9, 2008 CNSL S LETTER OF SUSPENSION MAILED Loading...
Jul 8, 2008 CNSL R SUSPENSION LETTER WRITTEN Loading...
Jun 11, 2008 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 11, 2008 ACEC I AMENDMENT FROM APPLICANT ENTERED Loading...
Jun 9, 2008 MAIL I PAPER RECEIVED Loading...
Mar 26, 2008 CNSI S INQUIRY AS TO SUSPENSION MAILED Loading...
Mar 25, 2008 CNSI R SUSPENSION INQUIRY WRITTEN Loading...
Feb 24, 2008 ALIE A ASSIGNED TO LIE Loading...

Detailed Classifications

Class 005
[ Host cells for medical or clinical use; cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies for medical or clinical use; transfected cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies for medical or clinical use; pharmaceuticals, namely, central nervous system depressants, preparations for ophthalmic use, anti-histaminics, cardiotonics, arrhythmia treating agents, diuretics, hypotensors, prophylactic for the treatment of asthma, antitussives and expectorants, stomachics and digestives, antacids, hormones, namely, pituitary hormones for the treatment of infertility, thyroid hormones for the treatment of hyperthyroidism, anabolic hormones for the treatment of aplastic anemia and osteoporosis, corticosteroids for treatment of hypopituitarism, congenital adrenal hyperplasia, rheumatoid arthritis, rheumatic fever, crohn's disease, and chronic active hepatitis, estrogen and progesterone used as combined oral contraceptives, urinary antiseptics, analgesics, anti-itching agents, cataplasms for the treatment of bruises, lumbago and stiff shoulder, pharmaceutical preparations used to treat hair disorders, vitamin preparations, food enriching agents for treating vitamin deficiencies, anti-coagulants, enzyme preparations for control of malabsorption and diarrhea, anti-cancer preparations, anti-sarcoma preparations, antibiotics and their preparations for the treatment of infectious diseases, antituberculotic agents, influenza vaccines, diphtheria vaccines, tetanus vaccines, gas gangrene vaccines, Japanese encephalitis vaccines, in vitro tetrodotoxines for medical use, antiprotozoals for the treatment of trichomoniasis and dermatophytosis, anthelmintics for the treatment of threadworm and toxoplasmaosis, naturally occurring drugs for treating peptic ulcers, charred drugs for treating peptic ulcers, moxa for treating peptic ulcers, veterinary drugs for the treatment of distemper in dogs, distomatosis in dogs, coccidian in chickens, and dysentery in pigs, germination controllers and plant rearing agents, namely, herbicides, fungicides, insecticides, bactericides and rodenticides for domestic and or agricultural use, antiseptics, drugs for arteriosclerosis, oncostatic drugs for the treatment for cancer, multienzyme digestants for in vivo use, antifungal antibiotics for treating trichomoniasis and dermatophytosis, anti parkinsonism drugs, minor tranquilizers, and anti anxiety agents, medicinal preparations for the treatment of the central nervous system, the respiratory tract and the cardiovascular system, anti-bacterial preparations, monolithic preparations, medicinal preparations for the treatment of peptic ulcers, anti-inflammatory preparations, analgesic preparations, cephalosporin, cocarboxylase preparations, glutathione preparations, preparations for improving the metabolism and the peripheral circulation, plasma substitutes and extracorporeal circulation flow improvement preparations, diuretic and anti-hypertensive preparations, in vitro diagnostic reagents for medical use, in vitro extra corporeal diagnostic reagents for medical use, in vitro x-ray contrast agents for medical use, in vitro diagnostic media, pharmaceutical preparations for the treatment of insomnia and other sleep related diseases ]
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005